Deprizine FusePaq and Morphine Extended-Release Capsules
Determining the interaction of Deprizine FusePaq and Morphine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranitidine
Brand name: Zantac
Synonyms: Ranitidine
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deprizine FusePaq-Morphine Immediate-Release Tablets and Capsules
- Deprizine FusePaq-Morphine injection
- Deprizine FusePaq-Morphine Injection PF
- Deprizine FusePaq-Morphine Long-Acting Tablets
- Deprizine FusePaq-Morphine Oral Concentrate (20 mg/mL)
- Deprizine FusePaq-Morphine Oral Solution
- Morphine Extended-Release Capsules-Derma Gran AF Topical
- Morphine Extended-Release Capsules-Derma Numb Spray
- Morphine Extended-Release Capsules-Derma-Smoothe/FS
- Morphine Extended-Release Capsules-Derma-Smoothe/FS (Body Oil)
- Morphine Extended-Release Capsules-Derma-Smoothe/FS (Scalp)
- Morphine Extended-Release Capsules-Derma-Smoothe/FS Body Oil (Fluocinolone Oil (Body Oil))